These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10194189)

  • 21. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles.
    Aliverti A; Macklem PT
    J Appl Physiol (1985); 2008 Aug; 105(2):749-51; discussion 755-7. PubMed ID: 18678622
    [No Abstract]   [Full Text] [Related]  

  • 22. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    O'Donnell D; Webb K
    J Appl Physiol (1985); 2008 Aug; 105(2):765. PubMed ID: 18678631
    [No Abstract]   [Full Text] [Related]  

  • 23. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Debigaré R; Maltais F
    J Appl Physiol (1985); 2008 Aug; 105(2):764. PubMed ID: 18678630
    [No Abstract]   [Full Text] [Related]  

  • 24. Last Word on Point:Counterpoint: The major limitation to exercise performance in COPD is 1) inadequate energy supply to the respiratory and locomotor muscles, 2) lower limb muscle dysfunction, 3) dynamic hyperinflation.
    Aliverti A; Macklem PT
    J Appl Physiol (1985); 2008 Aug; 105(2):763. PubMed ID: 18678629
    [No Abstract]   [Full Text] [Related]  

  • 25. Skeletal muscle abnormalities in patients with COPD: contribution to exercise intolerance.
    Serres I; Hayot M; Préfaut C; Mercier J
    Med Sci Sports Exerc; 1998 Jul; 30(7):1019-27. PubMed ID: 9662668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial.
    Schols AM; Soeters PB; Mostert R; Pluymers RJ; Wouters EF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1268-74. PubMed ID: 7551381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.
    Reid WD; Rurak J; Harris RL
    Crit Care Med; 2009 Oct; 37(10 Suppl):S372-83. PubMed ID: 20046123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease.
    Schols AM; Wouters EF
    Clin Chest Med; 2000 Dec; 21(4):753-62. PubMed ID: 11194784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of skeletal muscle myopathy to heart failure: novel mechanisms and therapies. Introduction.
    Chapleau MW
    Exp Physiol; 2014 Apr; 99(4):607-8. PubMed ID: 24692590
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current status of treatment of chronic obstructive pulmonary disease (discussion)].
    Nihon Naika Gakkai Zasshi; 1995 May; 84(5):768-85. PubMed ID: 7616090
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms and measures of exercise intolerance in chronic obstructive pulmonary disease.
    Nici L
    Clin Chest Med; 2000 Dec; 21(4):693-704. PubMed ID: 11194780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise limitation and pulmonary rehabilitation in chronic obstructive pulmonary disease.
    Olopade CO; Beck KC; Viggiano RW; Staats BA
    Mayo Clin Proc; 1992 Feb; 67(2):144-57. PubMed ID: 1545579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease.
    Jeffery Mador M; Kufel TJ; Pineda L
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):447-53. PubMed ID: 10673184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rehabilitative exercise training on peripheral muscle remodelling in patients with COPD: targeting beyond the lungs.
    Nasis I; Kortianou EA; Clini E; Koulouris NG; Vogiatzis I
    Curr Drug Targets; 2013 Feb; 14(2):262-73. PubMed ID: 23256723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender.
    Pinto-Plata VM; Celli-Cruz RA; Vassaux C; Torre-Bouscoulet L; Mendes A; Rassulo J; Celli BR
    Chest; 2007 Oct; 132(4):1204-11. PubMed ID: 17934113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease].
    Sauleda Roig J
    Nutr Hosp; 2006 May; 21 Suppl 3():69-75. PubMed ID: 16768033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambulatory oxygen in chronic obstructive pulmonary disease.
    Wedzicha JA
    Monaldi Arch Chest Dis; 1996 Jun; 51(3):243-5. PubMed ID: 8766202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle-energetic and cardio-pulmonary determinants of exercise tolerance in humans: Muscle-energetic and cardio-pulmonary determinants of exercise tolerance in humans.
    Ward SA
    Exp Physiol; 2007 Mar; 92(2):321-2. PubMed ID: 17360933
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary rehabilitation in chronic obstructive pulmonary disease.
    Folgering H; Rooyackers J
    Eur Respir J; 1998 Mar; 11(3):520-3. PubMed ID: 9596095
    [No Abstract]   [Full Text] [Related]  

  • 40. Nutrition in chronic obstructive pulmonary disease.
    Schols AM
    Curr Opin Pulm Med; 2000 Mar; 6(2):110-5. PubMed ID: 10741769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.